Cadrenal Therapeutics, Inc. (CVKD) Operating cash flow 2023–2025
Cadrenal Therapeutics, Inc. (CVKD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$12.6MFY2025 · since FY2023: -$3.5M → -$12.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.6M | -71.3% |
| FY2024 | -$7.4M | -108.4% |
| FY2023 | -$3.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CVKD financial trends
CVKD RevenueCVKD Net incomeCVKD Net marginCVKD Gross profitCVKD Gross marginCVKD Operating incomeCVKD Operating marginCVKD Free cash flowCVKD Capital expendituresCVKD Return on equityCVKD Stock buybacksCVKD Dividends paidCVKD Total assetsCVKD Total liabilitiesCVKD Shareholders’ equityCVKD overview →